Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Health...(business performance. Thomson Healthcare...),Health

Date:9/18/2007

business performance. Thomson Healthcare products and services help clinicians, hospitals, employers, health plans, government agencies, and pharmaceutical companies manage the cost and improve the quality of healthcare. Thomson Healthcare is a part of The Thomson Corporation, a provider of value-added information, software tools and applications to professionals in the fields of healthcare, law, tax, accounting, scientific research, and financial services. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC). For more information, visit (http://www.thomsonhealthcare.com).

About Supportive Oncology Services, Inc. (SOS)

Supportive Oncology Services, Inc. (SOS) is an information and outcomes company working closely with community oncology practices and oncology academic centers who touch over a half million cancer patients across the US and in Singapore. SOS collaborates with cancer providers, patients, payers, bio-technology and pharmaceutical companies, the financial industry, and other cancer-related industry leaders on a diverse set of clinical, financial, and operational initiatives. By continuously offering improvements, measuring results and providing value to the patient, SOS helps cancer clinics define and indisputably improve the quality of cancer care provided. For more information, visit http://www.supportiveoncologyservices.com.

About Accelerated Community Oncology Research Network, Inc. (ACORN)

The ACORN network includes over 30 progressive community oncology practices located throughout the U.S. and in Sin
'/>"/>

SOURCE Thomson Healthcare Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes
2. Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
3. Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma
4. July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia
5. NovaDel Announces Positive Data from Two Studies Comparing Zolpidem Oral Spray to Ambien Tablets
6. Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant
7. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
8. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
9. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease